MARTIN ARKIN, M.D.
Cornea and External Diseases Specialist Physician in TRAVERSE CITY, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: MARTIN ARKIN, M.D. reported a CMS MIPS final score of 75 out of 100, below the 83.1 national average, and filed 1,367 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
MARTIN ARKIN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
MARTIN ARKIN, M.D. at a glance
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Michigan
How Cornea and External Diseases Specialist Physician compares to other specialties among Michigan providers
Cornea and External Diseases Specialist Physician share within Michigan
Cornea and External Diseases Specialist Physician is one of the more visible NUCC categories in Michigan
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MARTIN ARKIN, M.D.'s 2023 MIPS final score plotted against the Cornea and External Diseases Specialist Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Cornea and External Diseases Specialist Physician) — 75/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Cornea and External Diseases Specialist Physician US NPIs
75/100 MIPS final score — 8.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Cornea and External Diseases Specialist Physician.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARTIN ARKIN, M.D. is a Cornea and External Diseases Specialist Physician provider practicing in TRAVERSE CITY, Michigan, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1699750356. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
MARTIN ARKIN, M.D. appears in the CMS NPPES registry as a Cornea and External Diseases Specialist Physician provider holding M.D. credentials at 10161 E PICKWICK CT, TRAVERSE CITY, MI, 49684, with a listed phone of (231) 935-0630. NPI 1699750356 was issued on 12/14/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ARKIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,367 prescription claims written by this provider, covering 306 Medicare beneficiaries and totaling roughly $60K in drug spend, split 24% brand-name and 76% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Cornea and External Diseases Specialist Physician is a narrow specialty nationwide, with 294 enrolled providers across 43 states and an average of 1,232 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1699750356 |
|---|---|
| Specialty | Cornea and External Diseases Specialist Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 12/14/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARTIN ARKIN, M.D.'s current license status, disciplinary history, and board certifications with the Michigan Department of Licensing and Regulatory Affairs in Michigan before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARTIN ARKIN, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$25
Largest payer
Tarsus Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Michigan MI-BOM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to MARTIN ARKIN, M.D.. To verify MARTIN ARKIN, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
24% brand-name claims vs 76% generic, on 1,367 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,258
- Total Day Supply
- 60,541
- Brand vs Generic
- 24% brand / 76% generic
- Brand Drug Cost
- $31K
- Generic Drug Cost
- $29K
- Antibiotic Claims
- 17
Patient Demographics
- Average Patient Age
- 76.9 years
- Avg HCC Risk Score
- 1.12
- Gender Split
- 58% female / 42% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Latanoprost | 289 |
| Prednisolone Acetate | 176 |
| Erythromycin Erythromycin Base | 155 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 130 |
| Ofloxacin | 126 |
| Ketorolac Tromethamine | 94 |
| Brimonidine Tartrate | 90 |
| Timolol Maleate | 81 |
| Pilocarpine Hcl | 45 |
| Dorzolamide Hcl | 42 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cornea and External Diseases Specialist Physician Overview
How MARTIN ARKIN, M.D. fits within the Cornea and External Diseases Specialist Physician landscape nationally.
MARTIN ARKIN, M.D.'s 1,367 claims are above the specialty average of 1,232.
Nearby Cornea and External Diseases Specialist Physician Providers in Michigan
Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as ARKIN.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Michigan
Frequently Asked Questions
What is MARTIN ARKIN, M.D.'s specialty? ▼
How much does MARTIN ARKIN, M.D. prescribe under Medicare Part D? ▼
What is MARTIN ARKIN, M.D.'s Medicare quality score? ▼
Where is MARTIN ARKIN, M.D. located? ▼
What is MARTIN ARKIN, M.D.'s NPI number? ▼
Does MARTIN ARKIN, M.D. prescribe more brand-name or generic drugs? ▼
How many Cornea and External Diseases Specialist Physician providers are there in the US? ▼
What drugs does MARTIN ARKIN, M.D. prescribe most often? ▼
Does MARTIN ARKIN, M.D. accept Medicare? ▼
How can I verify MARTIN ARKIN, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology